124 related articles for article (PubMed ID: 15095144)
1. Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro.
Baolin L; Inami Y; Tanaka H; Inagaki N; Iinuma M; Nagai H
Planta Med; 2004 Apr; 70(4):305-9. PubMed ID: 15095144
[TBL] [Abstract][Full Text] [Related]
2. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids.
Robin JL; Seldin DC; Austen KF; Lewis RA
J Immunol; 1985 Oct; 135(4):2719-26. PubMed ID: 3161947
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol preferentially inhibits IgE-dependent PGD2 biosynthesis but enhances TNF production from human skin mast cells.
Shirley D; McHale C; Gomez G
Biochim Biophys Acta; 2016 Apr; 1860(4):678-85. PubMed ID: 26777630
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin D2 generation in mouse bone marrow-derived mast cells exposed to dexamethasone is associated with endogenous peroxidase activity.
Michel L; Pitton C; Prost C; Massé JM; Mencia-Huerta JM; Burtin C; Maclouf J; Breton-Gorius J; Benveniste J; Dubertret L
Lab Invest; 1988 Nov; 59(5):613-24. PubMed ID: 2460694
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the anti-inflammatory effect of FK-506 on human mast cells.
de Paulis A; Cirillo R; Ciccarelli A; de Crescenzo G; Oriente A; Marone G
J Immunol; 1991 Dec; 147(12):4278-85. PubMed ID: 1721644
[TBL] [Abstract][Full Text] [Related]
7. Effect of Dracocephalum argunense on mast-cell-mediated hypersensitivity.
Kim SH; Shin TY
Int Arch Allergy Immunol; 2006; 139(2):87-95. PubMed ID: 16357489
[TBL] [Abstract][Full Text] [Related]
8. Suppression of mast cell-mediated allergic reaction by Amomum xanthiodes.
Kim SH; Lee S; Kim IK; Kwon TK; Moon JY; Park WH; Shin TY
Food Chem Toxicol; 2007 Nov; 45(11):2138-44. PubMed ID: 17602813
[TBL] [Abstract][Full Text] [Related]
9. IL-4 renders mast cells functionally responsive to endothelin-1.
Egger D; Geuenich S; Denzlinger C; Schmitt E; Mailhammer R; Ehrenreich H; Dörmer P; Hültner L
J Immunol; 1995 Feb; 154(4):1830-7. PubMed ID: 7530742
[TBL] [Abstract][Full Text] [Related]
10. Strain difference of murine bone marrow-derived mast cell functions.
Noguchi J; Kuroda E; Yamashita U
J Leukoc Biol; 2005 Sep; 78(3):605-11. PubMed ID: 16126842
[TBL] [Abstract][Full Text] [Related]
11. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone.
Benhamou M; Ninio E; Salem P; Hieblot C; Bessou G; Pitton C; Liu FT; Mencia-Huerta JM
J Immunol; 1986 Feb; 136(4):1385-92. PubMed ID: 2935578
[TBL] [Abstract][Full Text] [Related]
12. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
13. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells.
Mencia-Huerta JM; Razin E; Ringel EW; Corey EJ; Hoover D; Austen KF; Lewis RA
J Immunol; 1983 Apr; 130(4):1885-90. PubMed ID: 6300233
[TBL] [Abstract][Full Text] [Related]
14. [The culture of mouse bone marrow-derived mast cells (BMMC) and the anaphylactic release of chemical mediators].
Yamamura H; Ohkawa E; Kohno S; Ohata K
Arerugi; 1992 Sep; 41(9):1367-79. PubMed ID: 1280088
[TBL] [Abstract][Full Text] [Related]
15. Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells.
Cerrato S; Brazis P; della Valle MF; Miolo A; Puigdemont A
Vet Immunol Immunopathol; 2010 Jan; 133(1):9-15. PubMed ID: 19625089
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of cysteinyl leukotriene production in mast cells by heat shock and acetylsalicylic acid.
Mortaz E; Redegeld FA; Dunsmore K; Odoms K; Wong HR; Nijkamp FP; Engels F
Eur J Pharmacol; 2007 Apr; 561(1-3):214-9. PubMed ID: 17306251
[TBL] [Abstract][Full Text] [Related]
17. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
[TBL] [Abstract][Full Text] [Related]
18. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
19. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells.
Kim SH; Jun CD; Suk K; Choi BJ; Lim H; Park S; Lee SH; Shin HY; Kim DK; Shin TY
Toxicol Sci; 2006 May; 91(1):123-31. PubMed ID: 16322071
[TBL] [Abstract][Full Text] [Related]
20. Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity.
Haberl C; Hültner L; Flügel A; Falk M; Geuenich S; Wilmanns W; Denzlinger C
Mediators Inflamm; 1998; 7(2):79-84. PubMed ID: 9836493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
